JSS PHARMA LIMITED - ILFORD
| Company Profile | Company Filings |
Overview
JSS PHARMA LIMITED is a Private Limited Company from ILFORD UNITED KINGDOM and has the status: Dissolved - no longer trading.
JSS PHARMA LIMITED was incorporated 6 years ago on 18/08/2017 and has the registered number: 10922438. The accounts status is TOTAL EXEMPTION FULL.
JSS PHARMA LIMITED was incorporated 6 years ago on 18/08/2017 and has the registered number: 10922438. The accounts status is TOTAL EXEMPTION FULL.
JSS PHARMA LIMITED - ILFORD
This company is listed in the following categories:
86900 - Other human health activities
86900 - Other human health activities
Accounts Status
| Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
|---|---|---|
| 31 / 3 | 31/03/2021 |
Registered Office
962 EASTERN AVENUE
ILFORD
ESSEX
IG2 7JD
UNITED KINGDOM
This Company Originates in : United Kingdom
Confirmation Statements
| Last Statement | Next Statement Due |
|---|---|
| 09/08/2021 | 23/08/2022 |
Map
UNITED KINGDOM
Company Officers - Current and Previous
| Name | Born | Nationality | Role | Appointed | Status |
|---|---|---|---|---|---|
| MR JUGRAAJ SINGH SANGHA | Aug 1993 | British | Director | 2017-08-18 | CURRENT |
Persons with Significant Control
| Name | Active from | Born | Address | Level of control |
|---|---|---|---|---|
| Jugraaj Singh Sangha | 2017-08-18 | 8/1993 | Ilford Essex |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
Free Reports Available
| Report | Date Filed | Date of Report | Assets |
|---|---|---|---|
| JSS_Pharma_Limited_31_Mar_2021_companies_house_set_of_accounts.html | 2021-11-06 | 31-03-2021 | £37 Cash £486 equity |
| JSS_Pharma_Limited_31_Mar_2020_companies_house_set_of_accounts.html | 2020-11-21 | 31-03-2020 | £96 Cash £751 equity |
| JSS_Pharma_Limited_31_Mar_2019_companies_house_set_of_accounts.html | 2019-12-31 | 31-03-2019 | £37 Cash £439 equity |
| JSS Pharma Limited - Accounts to registrar (filleted) - small 18.2 | 2018-09-27 | 31-03-2018 | £269 equity |